Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
- Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)Active Not Recruiting
Sponsor: Atish Choudhury, MD
Prostate Cancer · Advanced Prostate Cancer · Hormone Sensitive Prostate Cancer
United States
Sponsor: Pfizer
Melanoma
Germany, Italy, Poland, Slovakia, Spain
- Palbociclib in Patients With Metastatic Castration-Resistant Prostate CancerActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Prostate Cancer
Canada
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)Active Not Recruiting
Sponsor: Pfizer
Breast Cancer
United States, Canada, Italy, Spain
Sponsor: University of Oklahoma
Androgen Deprivation Therapy · Locally Advanced Prostate Cancer
United States
- Talazoparib and Thoracic RT for ES-SCLCRecruiting
Sponsor: University Health Network, Toronto
Lung Cancer · Small-Cell Lung Cancer
Canada
- Implementation Strategies for Monitoring Adherence in Real TimeActive Not Recruiting
Sponsor: Abramson Cancer Center at Penn Medicine
Lung Cancer · Medication Adherence · Symptoms and Signs
United States
- Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With LupusCompleted
Sponsor: Children's Hospital Medical Center, Cincinnati
Cutaneous Lupus · Systemic Lupus Erythematosus
United States
- Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaRecruiting
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Melanoma Stage III · Melanoma Stage IV · BRAF V600 Mutation
United States
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Leptomeningeal Metastases · Leptomeningeal Disease
United States
- Litfulo Capsules Special InvestigationActive Not Recruiting
Sponsor: Pfizer
Alopecia Areata
Japan
- Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/ParagangliomaActive Not Recruiting
Sponsor: Columbia University
Pheochromocytoma · Paraganglioma
United States
Sponsor: Pfizer
Metastatic Renal Cell Carcinoma (mRCC)
Austria, Belgium, France, Greece, Italy +3 more
Sponsor: Pfizer
Breast Cancer
United States
Sponsor: Pfizer
Melanoma
United States, Argentina, Australia, Brazil, Canada +24 more
Sponsor: Pfizer
Stable Nonsegmental Vitiligo · Active Nonsegmental Vitiligo
United States, Australia, Bulgaria, Canada, China +10 more
- A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Active Not Recruiting
Sponsor: Pfizer
Breast Cancer
United States, Belgium, Canada, China, France +3 more
Sponsor: Pfizer
Ulcerative Colitis
United States, Germany, Poland
- Talazoparib for Cohesin-Mutated AML and MDS With Excess BlastsActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Leukemia
United States
- A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese AdultsCompleted
Sponsor: Pfizer
Pneumococcal Disease
China
Sponsor: Indiana University
Prostate Cancer
United States
Sponsor: Pfizer
Prostatic Neoplasms, Castration-Resistant
United States
Sponsor: Emory University
Recurrent Prostate Carcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8
United States
- Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Carcinoma · Gastric Adenocarcinoma · GEJ Adenocarcinoma · Esophageal Adenocarcinoma
United States, Japan
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Cervical Cancer
United States, Argentina, Austria, Belgium, Brazil +20 more